Biolidics Limited (SGX:8YY)

Biolidics Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	39	49	9	12	50	79
Market Cap Growth	432.57%	432.57%	-22.25%	-76.52%	-36.33%	33.33%
Enterprise Value	40	51	9	15	48	74
Last Close Price	0.02	0.03	0.01	0.02	0.18	0.28
PS Ratio	26.32	57.15	6.77	4.45	21.66	8.54
PB Ratio	37.58	47.33	-4.63	-7.01	21.63	9.58
P/TBV Ratio	-	-	-	-	-	20.47
EV/Sales Ratio	47.02	59.79	6.83	5.49	20.41	7.99
Debt / Equity Ratio	1.69	1.69	-1.02	-1.78	1.82	0.64
Asset Turnover	0.37	0.37	0.40	0.30	0.15	0.65
Inventory Turnover	-	-	40.74	1.78	1.41	4.35
Quick Ratio	0.25	0.25	0.15	0.94	1.77	4.79
Current Ratio	0.26	0.26	0.22	0.99	2.53	5.65
Return on Equity (ROE)	-	-	-	-2911.18%	-112.86%	-58.00%
Return on Assets (ROA)	-85.67%	-85.67%	-45.57%	-41.14%	-25.59%	-18.55%
Return on Capital (ROIC)	-141.18%	-141.18%	-227.00%	-91.13%	-38.36%	-24.09%
Earnings Yield	-8.83%	-7.00%	-27.02%	-79.17%	-11.87%	-5.87%
FCF Yield	-1.78%	-1.41%	-21.35%	-26.16%	-10.05%	-3.48%
Buyback Yield / Dilution	-65.44%	-65.44%	-110.56%	-6.21%	-3.01%	-6.17%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.